Shionogi & Co., Ltd. - Product Pipeline Review - 2013

Publisher Name :
Date: 31-Jul-2013
No. of pages: 78
Inquire Before Buying

Shionogi & Co., Ltd. - Product Pipeline Review - 2013

Summary

Global Markets Direct's pharmaceuticals report, "Shionogi & Co., Ltd. - Product Pipeline Review - 2013" provides data on the Shionogi & Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Shionogi & Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Shionogi & Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Shionogi & Co., Ltd. - Brief Shionogi & Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of Shionogi & Co., Ltd. human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Shionogi & Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the Shionogi & Co., Ltd.'s pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Shionogi & Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of Shionogi & Co., Ltd. in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the Shionogi & Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Shionogi & Co., Ltd..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Shionogi & Co., Ltd. and identify potential opportunities in those areas.

Shionogi & Co., Ltd. - Product Pipeline Review - 2013

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 7
Shionogi & Co., Ltd. Snapshot 8
Shionogi & Co., Ltd. Overview 8
Key Information 8
Key Facts 8
Shionogi & Co., Ltd. - Research and Development Overview 9
Key Therapeutic Areas 9
Shionogi & Co., Ltd. - Pipeline Review 14
Pipeline Products by Stage of Development 14
Pipeline Products - Monotherapy 15
Pipeline Products - Combination Treatment Modalities 16
Shionogi & Co., Ltd. - Pipeline Products Glance 17
Shionogi & Co., Ltd. - Late Stage Pipeline 17
Phase III Products/Combination Treatment Modalities 17
Shionogi & Co., Ltd. Clinical Stage Pipeline Products 18
Phase II Products/Combination Treatment Modalities 18
Phase I Products/Combination Treatment Modalities 19
Shionogi & Co., Ltd. - Early Stage Pipeline Products 20
Preclinical Products/Combination Treatment Modalities 20
Discovery Products/Combination Treatment Modalities 21
Shionogi & Co., Ltd. - Drug Profiles 22
(irbesartan + trichlormethiazide) 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
(lidocaine + prilocaine) 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
39-f 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Actair 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Benzimidazole Derivative 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Beta-Secretase Inhibitor 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Compound-18e 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
doripenem 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
duloxetine hydrochloride DR 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
guanfacine hydrochloride ER 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
interferon gamma-1a 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Japanese Cedar Pollen Tablet 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
lisdexamfetamine dimesylate 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
lusutrombopag 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
naldemedine 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
ospemifene 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
oxycodone hydrochloride 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
P2X3 Receptor Antagonist 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Peptide Cocktail Vaccine 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
prednisolone acetate 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
S-117957 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
S-120083 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
S-222611 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
S-234462 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
S-288310 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
S-488210 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
S-488410 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
S-555739 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
S-556971 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
S-646240 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
S-649266 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
S-707106 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
velneperit 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Shionogi & Co., Ltd. - Pipeline Analysis 55
Shionogi & Co., Ltd. - Pipeline Products by Therapeutic Class 55
Shionogi & Co., Ltd. - Pipeline Products By Target 59
Shionogi & Co., Ltd. - Pipeline Products by Route of Administration 60
Shionogi & Co., Ltd. - Pipeline Products By Mechanism of Action 61
Shionogi & Co., Ltd. - Recent Pipeline Updates 63
Shionogi & Co., Ltd. - Dormant Projects 69
Shionogi & Co., Ltd. - Discontinued Pipeline Products 70
Discontinued Pipeline Product Profiles 70
ADX-415 70
clonidine hydrochloride 70
doripenem 70
lusutrombopag 71
S-444823 71
S-5751 71
S-777469 71
S-8510 71
teceleukin 72
velneperit 72
Shionogi & Co., Ltd. - Company Statement 73
Shionogi & Co., Ltd. - Locations And Subsidiaries 74
Head Office 74
Other Locations & Subsidiaries 74
Shionogi & Co., Ltd. - Key Manufacturing Facilities 76
Appendix 77
Methodology 77
Coverage 77
Secondary Research 77
Primary Research 77
Expert Panel Validation 77
Contact Us 78
Disclaimer 78

List of Tables
Shionogi & Co., Ltd., Key Information 8
Shionogi & Co., Ltd., Key Facts 8
Shionogi & Co., Ltd. - Pipeline by Indication, 2013 12
Shionogi & Co., Ltd. - Pipeline by Stage of Development, 2013 14
Shionogi & Co., Ltd. - Monotherapy Products in Pipeline, 2013 15
Shionogi & Co., Ltd. - Combination Treatment Modalities in Pipeline, 2013 16
Shionogi & Co., Ltd. - Phase III, 2013 17
Shionogi & Co., Ltd. - Phase II, 2013 18
Shionogi & Co., Ltd. - Phase I, 2013 19
Shionogi & Co., Ltd. - Preclinical, 2013 20
Shionogi & Co., Ltd. - Discovery, 2013 21
Shionogi & Co., Ltd. - Pipeline By Therapeutic Class, 2013 56
Shionogi & Co., Ltd. - Pipeline By Target, 2013 59
Shionogi & Co., Ltd. - Pipeline By Route of Administration, 2013 60
Shionogi & Co., Ltd. - Pipeline Products By Mechanism of Action, 2013 61
Shionogi & Co., Ltd. - Recent Pipeline Updates, 2013 63
Shionogi & Co., Ltd. - Dormant Developmental Projects,2013 69
Shionogi & Co., Ltd. - Discontinued Pipeline Products, 2013 70
Shionogi & Co., Ltd., Other Locations 74
Shionogi & Co., Ltd., Subsidiaries 75
Shionogi & Co., Ltd., Key Manufacturing Facilities 76

List of Figures
Shionogi & Co., Ltd. - Pipeline by Indication, 2013 11
Shionogi & Co., Ltd. - Pipeline by Stage of Development, 2013 14
Shionogi & Co., Ltd. - Monotherapy Products in Pipeline, 2013 15
Shionogi & Co., Ltd. - Combination Treatment Modalities in Pipeline, 2013 16
Shionogi & Co., Ltd. - Pipeline By Therapeutic Class, 2013 55
Shionogi & Co., Ltd. - Pipeline By Route of Administration, 2013 60
Shionogi & Co., Ltd. - Pipeline Products By Mechanism of Action, 2013 61
  • Zinc Bromide Industry Analysis, Trends and Forecast to 2020
    Global and Chinese Zinc Bromide (CAS7699-45-8) Industry, 2015 Market Research Report is a comprehensive research and 2015 market analysis by Prof Research, incorporating all the major phases and current market trends of in the Global and Chinese Zinc Bromide (CAS7699-45-8) Industry/market. The report commence with a brief introduction to the Zinc Bromide (CAS7699-45-8) along with [...]
  • Where is Healthcare Cloud Computing Market Going in Next 5 Years?
    Constant upsurge of IT n the field of healthcare has opened-up new business opportunities for cloud computing in the healthcare market. The basic requirement of cloud computing in healthcare industry is data-storage and data-integration that allows smooth data-access whenever required. Also, the need to collaborate a technologically advanced coordination between the patient and physician is [...]
  • Terminal Antennas Industry 2020 Forecasts for Global and Chinese Regions by Classification, Application & Manufacturing Technology
    Introduction: 2015 Terminal Antennas Industry Report – Global and Chinese Market 2015 Terminal Antennas Industry Report – Global and Chinese Market Scenario provide a detailed business insight on the trends of global and Chinese market. The report initially focuses on the existing technologies being used in the production of terminal antenas, the evolution of the [...]
  • Aluminum Heat Exchanger Consumption by Application and Type
    Global and Chinese Aluminum Heat Exchanger Industry, 2009-2019 Market Research Report is an in-depth market analysis of the current business situation and happenings of the Aluminum Heat Exchanger Industry. The report commence with a brief introduction to the industry, providing a description of the terminology used in the industry. The report further shares crucial stats [...]
  • Global and Chinese Calcium Heparin Market 2015 Analysis
    Synopsis – 2015 Calcium heparin Industry Report – Global and Chinese Market Scenario offers a thorough analysis of the entire Calcium Heparin industry. This report reviews each and every aspect of the Calcium Heparin industry and helps in effective decision making procedure.  A systematic breakup is provided to track down all possible barriers that can [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Personalized Medicine
    Published: 01-Aug-2007        Price: US 1999 Onwards        Pages: 87
    Personalized medicine and pharmacogenomics are inextricably linked. Pharmacogenomics is the use of genetic variations (such as SNPs, gene expression variability, or other molecular signatures) to understand and correlate with differential response to pharmaceutical agents (drugs). Pharmacogenomics can be deployed clinically to stratify patients into responders and non-responders and this practice is termed personalized medicine. The purpose of this TriMark Publications report is to describe the ......
  • Indian Pharmaceutical Industry
    Published: 01-Jul-2008        Price: US 1999 Onwards        Pages: 207
    The purpose of this TriMark Publications study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry. This sector includes all of the generally-accepted pharmaceutical manufacturing activities that are currently used today, including the bulk drug industry, formulations and major therapeutic segments. It examines these clinical supplies as utilized in hospitals, clinics and doctor's offices. The principal objectives of this analysis are......
  • The Pharmaceutical Industry 2009 - The Key R&D Trends Impacting New Product Development
    Published: 15-Apr-2009        Price: US 3900 Onwards        Pages: 46
    The Pharmaceutical Industry 2009 - The Key R&D Trends Impacting New Product Development Summary Despite the current economic downturn, pharmaceutical research and development spending continues to play a vital role in the pharmaceutical industry. Recent trends indicate a consolidation of efforts through numerous acquisitions, both intra-pharmaceutical as well as purchases of biotechs by big pharma. In addition, pharmaceutical companies are narrowing the......
  • The Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget
    Published: 15-Jun-2009        Price: US 3900 Onwards        Pages: 54
    The Obama Administration and the Pharmaceutical Industry - Overview of the 2009 Recovery Act and the 2010 Federal Budget Summary President Obama has made healthcare reform one of his administration's top priorities. Towards this goal, several billion dollars have been provided through the Recovery Act and 2010 Budget for initiatives that are intended to make the US healthcare system safer and more cost-effective. These include - - conducting comparative effec......
  • The Economy and the Pharmaceutical Industry - Adherence to Drug Treatments and How the Current Economic Environment is Affecting Patients' Treatment Choices
    Published: 15-Nov-2009        Price: US 3900 Onwards        Pages: 57
    The Economy and the Pharmaceutical Industry - Adherence to Drug Treatments and How the Current Economic Environment is Affecting Patients' Treatment Choices Summary The ongoing US recession is affecting consumers' behavior in the healthcare market. The rising unemployment rate means that fewer individuals are covered under generous employer sponsored health insurance plans. Many people who lose their jobs also lose their ability to cover the costs of healthcare, inc......
  • The Pharmaceutical Year in Review 2009 - Industry Trends and Lessons Learned
    Published: 15-Dec-2009        Price: US 3900 Onwards        Pages: 67
    The Pharmaceutical Year in Review 2009 - Industry Trends and Lessons Learned Summary 2009 has been a turbulent year for the global economy and the increasing interconnectivity of business has amplified its impact on the pharmaceutical industry. As a result of the global recession, the pharmaceutical industry has seen a greater urgency to adapt its ways in order to continue to sustain any substantial growth. Several key events & trends have been seen ove......
  • The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
    Published: 15-Mar-2010        Price: US 1000 Onwards        Pages: 54
    Report Summary GBI Research has released “The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity”. The study, which is an offering from the company’s Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regi......
  • Emerging Market Strategies - Mapping the opportunities for pharmaceutical expansion
    Published: 15-Apr-2010        Price: US 3900 Onwards        Pages: 54
    Emerging Market Strategies - Mapping the opportunities for pharmaceutical expansion Summary With a variety of factors impacting pharmaceutical growth in the traditional markets (the US, 5EU and Japan) - price controls, moves towards generics, healthcare reform, market saturation - the emerging markets (EMs) hold increasing potential to drive future product sales and overall company revenues. The different situations which exist within each emerging mark......
  • Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
    Published: 01-Oct-2010        Price: US 1000 Onwards        Pages: 114
    Report Summary GBI Research has released its Chemical research, “Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth”. The report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, pro......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs